Cargando…

BRCA1 testing

Detalles Bibliográficos
Autores principales:	Górski, Bohdan, Lubiński, Jan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735416/ https://www.ncbi.nlm.nih.gov/pubmed/19804601 http://dx.doi.org/10.1186/1897-4287-6-2-81

Ejemplares similares

A common missense variant in BRCA2 predisposes to early onset breast cancer
por: Górski, Bohdan, et al.
Publicado: (2005)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population
por: Górski, Bohdan
Publicado: (2006)

BRCA Testing Dichotomy in Saudi Arabia
por: Abusanad, Atlal
Publicado: (2019)

Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism
por: Jakubowska, Anna, et al.
Publicado: (2008)

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet
por: Huzarski, Tomasz, et al.
Publicado: (2006)

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
por: Chenevix-Trench, Georgia, et al.
Publicado: (2007)

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008)

Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?
por: Gareth Evans, D, et al.
Publicado: (2004)

Distinct functions of BRCA1 and BRCA2 in double-strand break repair
por: Liu, Yilun, et al.
Publicado: (2002)

Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?
por: McAllister, Kimberly A, et al.
Publicado: (2002)

Prediction of carrying a BRCA1 or BRCA2 mutation
por: Lee, Kyung-Hun
Publicado: (2023)

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
por: Savanevich, Alena, et al.
Publicado: (2021)

A commentary on the discrepancy between blood and tumour BRCA testing: An open question
por: De Paolis, Elisa, et al.
Publicado: (2022)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Caretaker Brca1: keeping the genome in the straight and narrow
por: Yu, Veronica
Publicado: (2000)

Looking for BRCA1 and BRCA2 mutations in Asian women with breast cancer
por: Narod, Steven A.
Publicado: (2023)

BRCA2 and homologous recombination
por: Orelli, Brian J, et al.
Publicado: (2001)

Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2)
por: Lubiński, Jan
Publicado: (2005)

Cisplatin in breast cancer treatment in BRCA1 carriers
por: Gronwald, Jacek, et al.
Publicado: (2012)

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population
por: Dębniak, Tadeusz, et al.
Publicado: (2018)

Immunophenotypic predictive profiling of BRCA1-associated breast cancer
por: Domagala, Pawel, et al.
Publicado: (2010)

Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland
por: Jasiewicz, Andrzej, et al.
Publicado: (2022)

Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
por: Imyanitov, Evgeny N
Publicado: (2009)

Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
Publicado: (2007)

BRCA1 function in T lymphocytes: a cellular specificity of a different kind
por: Gardner, Kevin, et al.
Publicado: (2001)

Selenium and the risk of cancer in BRCA1 carriers
por: Lubinski, J, et al.
Publicado: (2011)

MSH6 syndrome
por: Suchy, Janina, et al.
Publicado: (2008)

Principles of genetic predisposition to malignancies
por: Dębniak, Tadeusz, et al.
Publicado: (2008)

Lynch syndrome (HNPCC)
por: Kładny, Józef, et al.
Publicado: (2008)

Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients
por: Synowiec, Agnieszka, et al.
Publicado: (2016)

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
por: Kluz, Tomasz, et al.
Publicado: (2018)

Methylation of BRCA1 promoter in sporadic breast cancer
por: Jagtap, Sunil Vitthalrao, et al.
Publicado: (2023)

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
por: Byrski, T, et al.
Publicado: (2011)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

DNA testing for variants conferring low or moderate increase in the risk of cancer
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

Role of BRCA gene dysfunction in breast and ovarian cancer predisposition
por: Scully, Ralph
Publicado: (2000)

BRCA role changes with association: tissue-specific impact on the prognosis
por: Gupta, Bhavana, et al.
Publicado: (2021)

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
por: Iqbal, Javaid, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_el78jpu591sqgafu95ht3re01s